PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
1.24 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 40.876 | 37.706 | 108.297 | 172.467 | 361.422 | 73.278 | 30.307 |
| Short Term Investments
| 128.578 | 165.351 | 132.757 | 124.696 | 0 | 28.208 | 31.6 |
| Cash and Short Term Investments
| 169.454 | 203.057 | 241.054 | 297.163 | 361.422 | 101.486 | 61.907 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.204 | 4.352 | 5.952 | 4.123 | 6.678 | 0.607 | 0.332 |
| Total Current Assets
| 175.658 | 207.409 | 247.006 | 301.286 | 364.761 | 102.093 | 62.239 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1.552 | 19.048 | 20.494 | 13.15 | 0.569 | 0.739 | 1.018 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 25.505 | 2.495 | 16.911 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 14.078 | 0.19 | 0.313 | 0.221 | 0.201 | 0.201 | 0.201 |
| Total Non-Current Assets
| 15.63 | 44.743 | 23.302 | 30.282 | 0.77 | 0.94 | 1.219 |
| Total Assets
| 191.288 | 252.152 | 270.308 | 331.568 | 365.531 | 103.033 | 63.458 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 6.579 | 3.237 | 2.996 | 3.189 | 1.607 | 2.837 | 1.038 |
| Short Term Debt
| 0.352 | 0.852 | 1.056 | 0.806 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 7.439 | 9.94 | 6.78 | 8.224 | 4.803 | 1.686 | 1.289 |
| Total Current Liabilities
| 14.37 | 14.029 | 10.832 | 12.219 | 6.41 | 4.523 | 2.327 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0.838 | 12.434 | 13.448 | 10.79 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 168.984 | 107.271 |
| Total Non-Current Liabilities
| 0.838 | 12.434 | 13.448 | 10.79 | 0 | 168.984 | 107.271 |
| Total Liabilities
| 15.208 | 26.463 | 24.28 | 23.009 | 6.41 | 173.507 | 109.598 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 365.531 | 0.169 | 107.228 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -368.712 | -310.003 | -241.043 | -167.726 | -109.88 | -75.44 | -50.088 |
| Accumulated Other Comprehensive Income/Loss
| 0.139 | 0.224 | -0.445 | -0.078 | 0 | -0.003 | -0.013 |
| Other Total Stockholders Equity
| 544.653 | 535.468 | 487.516 | 476.363 | 469.001 | 4.969 | 3.961 |
| Total Shareholders Equity
| 176.08 | 225.689 | 246.028 | 308.559 | 359.121 | -70.474 | -46.14 |
| Total Equity
| 176.08 | 225.689 | 246.028 | 308.559 | 359.121 | -70.474 | -46.14 |
| Total Liabilities & Shareholders Equity
| 191.288 | 252.152 | 270.308 | 331.568 | 365.531 | 103.033 | 63.458 |